Climate Change Data

Sight Sciences, Inc.

Climate Impact & Sustainability Data (2021-2023, 2022, 2024)

Reporting Period: 2021-2023

Environmental Metrics

ESG Focus Areas

  • Environmental
  • Social
  • Governance

Environmental Achievements

  • Reduced use of weekly air freight shipments and consolidated shipping to fewer monthly or bimonthly shipments using sea freight (Q1 2023)

Social Achievements

  • Supported 25 indigent care programs in over 10 countries (2021-2023)
  • Launched a Women in Leadership initiative in 2023
  • Achieved nearly 50% female representation in the workforce as of December 31, 2023

Governance Achievements

  • Adopted a Stock Ownership Policy for executive officers and non-employee directors to align interests with stockholders
  • Four of eight board members are women as of December 31, 2023, with a commitment to at least 40% female representation.

Climate Goals & Targets

Supply Chain Management

Climate-Related Risks & Opportunities

Reporting Period: 2022

Environmental Metrics

Total Carbon Emissions:Not disclosed
Scope 1 Emissions:Not disclosed
Scope 2 Emissions:Not disclosed
Scope 3 Emissions:Not disclosed
Renewable Energy Share:Not disclosed
Total Energy Consumption:Not disclosed
Water Consumption:Not disclosed
Waste Generated:Not disclosed
Carbon Intensity:Not disclosed

ESG Focus Areas

  • Not disclosed

Environmental Achievements

  • Not disclosed

Social Achievements

  • Improved dry eye signs and symptoms for 78 patients (156 eyes) for more than 12 months, with some cases up to 18 months, after a single TearCare® treatment. 44% decrease in dry eye symptoms from baseline to week 8, maintained through month 12.

Governance Achievements

  • Not disclosed

Climate Goals & Targets

Long-term Goals:
  • Not disclosed
Medium-term Goals:
  • Not disclosed
Short-term Goals:
  • Not disclosed

Environmental Challenges

  • Low adoption rate of interventional MGD procedures (approximately 5% of dry eye patients).
Mitigation Strategies
  • Providing clinical data demonstrating the durability of treatment effect with TearCare® to support greater adoption of the procedure. Addressing patient compliance issues and high monthly costs of daily prescription medications by offering a long-lasting alternative.

Supply Chain Management

Supplier Audits: Not disclosed

Responsible Procurement
  • Not disclosed

Climate-Related Risks & Opportunities

Physical Risks
  • Not disclosed
Transition Risks
  • Not disclosed
Opportunities
  • Not disclosed

Reporting Standards

Frameworks Used: Null

Certifications: Null

Third-party Assurance: Not disclosed

UN Sustainable Development Goals

  • Not disclosed

Not disclosed

Sustainable Products & Innovation

  • TearCare® System

Awards & Recognition

  • Not disclosed

Reporting Period: 2024

Environmental Metrics

Total Carbon Emissions:Not disclosed
Scope 1 Emissions:Not disclosed
Scope 2 Emissions:Not disclosed
Scope 3 Emissions:Not disclosed
Renewable Energy Share:Not disclosed
Total Energy Consumption:Not disclosed
Water Consumption:Not disclosed
Waste Generated:Not disclosed
Carbon Intensity:Not disclosed

ESG Focus Areas

  • Not disclosed

Environmental Achievements

  • Not disclosed

Social Achievements

  • Not disclosed

Governance Achievements

  • Not disclosed

Climate Goals & Targets

Long-term Goals:
  • Not disclosed
Medium-term Goals:
  • Not disclosed
Short-term Goals:
  • Not disclosed

Environmental Challenges

  • Not disclosed
Mitigation Strategies
  • Not disclosed

Supply Chain Management

Supplier Audits: Not disclosed

Responsible Procurement
  • Not disclosed

Climate-Related Risks & Opportunities

Physical Risks
  • Not disclosed
Transition Risks
  • Not disclosed
Opportunities
  • Not disclosed

Reporting Standards

Frameworks Used: Null

Certifications: Null

Third-party Assurance: Not disclosed

UN Sustainable Development Goals

  • Not disclosed

Not disclosed

Sustainable Products & Innovation

  • Not disclosed

Awards & Recognition

  • Not disclosed